 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
2 terms
|
 |
|
Biological process
|
immune response
|
2 terms
|
 |
|
Biochemical function
|
growth factor activity
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
86:9667-9671
(1989)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystallographic refinement of interleukin 1 beta at 2.0 A resolution.
|
|
J.P.Priestle,
H.P.Schär,
M.G.Grütter.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The structure of human recombinant interleukin 1 beta (IL-1 beta) has been
refined by a restrained least-squares method to a crystallographic R factor of
17.2% to 2.0 A resolution. One-hundred sixty-eight solvent molecules have been
located, and isotropic temperature factors for each atom have been refined. The
overall structure is composed of 12 beta-strands that can best be described as
forming the four triangular faces of a tetrahedron with hydrogen bonding
resembling normal antiparallel beta-sheets only at the vertices. The interior of
this tetrahedron is filled by hydrophobic side chains. Analysis of sequence
alignments with IL-1 beta from other mammalian species shows the interior to be
very well conserved with the exterior residues markedly less so. There does not
appear to be a clustering of invariant amino acid side chains on the surface of
the molecule, suggesting an area of interaction with the IL-1 receptor.
Comparison of the IL-1 beta structure with IL-1 alpha sequences indicates that
IL-1 alpha probably has a similar overall folding as IL-1 beta but binds to the
receptor in a different fashion. The three-dimensional structure of the IL-1
beta is analyzed in light of what has been suggested by previously published
work on mutants and fragments of the molecule.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Gabay,
C.Lamacchia,
and
G.Palmer
(2010).
IL-1 pathways in inflammation and human diseases.
|
| |
Nat Rev Rheumatol, 6,
232-241.
|
 |
|
|
|
|
 |
D.Wang,
S.Zhang,
L.Li,
X.Liu,
K.Mei,
and
X.Wang
(2010).
Structural insights into the assembly and activation of IL-1β with its receptors.
|
| |
Nat Immunol, 11,
905-911.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.F.Nold,
C.A.Nold-Petry,
J.A.Zepp,
B.E.Palmer,
P.Bufler,
and
C.A.Dinarello
(2010).
IL-37 is a fundamental inhibitor of innate immunity.
|
| |
Nat Immunol, 11,
1014-1022.
|
 |
|
|
|
|
 |
A.Lingel,
T.M.Weiss,
M.Niebuhr,
B.Pan,
B.A.Appleton,
C.Wiesmann,
J.F.Bazan,
and
W.J.Fairbrother
(2009).
Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes.
|
| |
Structure, 17,
1398-1410.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.W.Matthews,
and
L.Liu
(2009).
A review about nothing: are apolar cavities in proteins really empty?
|
| |
Protein Sci, 18,
494-502.
|
 |
|
|
|
|
 |
I.C.Wilkinson,
C.J.Hall,
V.Veverka,
J.Y.Shi,
F.W.Muskett,
P.E.Stephens,
R.J.Taylor,
A.J.Henry,
and
M.D.Carr
(2009).
High resolution NMR-based model for the structure of a scFv-IL-1beta complex: potential for NMR as a key tool in therapeutic antibody design and development.
|
| |
J Biol Chem, 284,
31928-31935.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.A.Vila,
Y.A.Arnautova,
O.A.Martin,
and
H.A.Scheraga
(2009).
Quantum-mechanics-derived 13Calpha chemical shift server (CheShift) for protein structure validation.
|
| |
Proc Natl Acad Sci U S A, 106,
16972-16977.
|
 |
|
|
|
|
 |
R.Kakkar,
and
R.T.Lee
(2008).
The IL-33/ST2 pathway: therapeutic target and novel biomarker.
|
| |
Nat Rev Drug Discov, 7,
827-840.
|
 |
|
|
|
|
 |
N.Kulahin,
V.Kiselyov,
A.Kochoyan,
O.Kristensen,
J.S.Kastrup,
V.Berezin,
E.Bock,
and
M.Gajhede
(2007).
Structure of rat acidic fibroblast growth factor at 1.4 A resolution.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun, 63,
65-68.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
V.Helms
(2007).
Protein dynamics tightly connected to the dynamics of surrounding and internal water molecules.
|
| |
Chemphyschem, 8,
23-33.
|
 |
|
|
|
|
 |
M.L.Quillin,
P.T.Wingfield,
and
B.W.Matthews
(2006).
Determination of solvent content in cavities in IL-1beta using experimentally phased electron density.
|
| |
Proc Natl Acad Sci U S A, 103,
19749-19753.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.J.Bernett,
T.Somasundaram,
and
M.Blaber
(2004).
An atomic resolution structure for human fibroblast growth factor 1.
|
| |
Proteins, 57,
626-634.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.G.Rudolph,
M.S.Kelker,
T.R.Schneider,
T.O.Yeates,
V.Oseroff,
D.K.Heidary,
P.A.Jennings,
and
I.A.Wilson
(2003).
Use of multiple anomalous dispersion to phase highly merohedrally twinned crystals of interleukin-1beta.
|
| |
Acta Crystallogr D Biol Crystallogr, 59,
290-298.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.R.Brych,
J.Kim,
T.M.Logan,
and
M.Blaber
(2003).
Accommodation of a highly symmetric core within a symmetric protein superfold.
|
| |
Protein Sci, 12,
2704-2718.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.Liu,
J.A.Gaspar,
H.J.Wong,
and
E.M.Meiering
(2002).
Conserved and nonconserved features of the folding pathway of hisactophilin, a beta-trefoil protein.
|
| |
Protein Sci, 11,
669-679.
|
 |
|
|
|
|
 |
D.Vitkup,
D.Ringe,
M.Karplus,
and
G.A.Petsko
(2002).
Why protein R-factors are so large: a self-consistent analysis.
|
| |
Proteins, 46,
345-354.
|
 |
|
|
|
|
 |
S.R.Brych,
S.I.Blaber,
T.M.Logan,
and
M.Blaber
(2001).
Structure and stability effects of mutations designed to increase the primary sequence symmetry within the core region of a beta-trefoil.
|
| |
Protein Sci, 10,
2587-2599.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.A.Chrunyk,
M.H.Rosner,
Y.Cong,
A.S.McColl,
I.G.Otterness,
and
G.O.Daumy
(2000).
Inhibiting protein-protein interactions: a model for antagonist design.
|
| |
Biochemistry, 39,
7092-7099.
|
 |
|
|
|
|
 |
B.Yu,
M.Blaber,
A.M.Gronenborn,
G.M.Clore,
and
D.L.Caspar
(1999).
Disordered water within a hydrophobic protein cavity visualized by x-ray crystallography.
|
| |
Proc Natl Acad Sci U S A, 96,
103-108.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.K.Dattagupta,
A.Podder,
C.Chakrabarti,
U.Sen,
D.Mukhopadhyay,
S.K.Dutta,
and
M.Singh
(1999).
Refined crystal structure (2.3 A) of a double-headed winged bean alpha-chymotrypsin inhibitor and location of its second reactive site.
|
| |
Proteins, 35,
321-331.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Ravichandran,
U.Sen,
C.Chakrabarti,
and
J.K.Dattagupta
(1999).
Cryocrystallography of a Kunitz-type serine protease inhibitor: the 90 K structure of winged bean chymotrypsin inhibitor (WCI) at 2.13 A resolution.
|
| |
Acta Crystallogr D Biol Crystallogr, 55,
1814-1821.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.A.Dinarello
(1998).
Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist.
|
| |
Int Rev Immunol, 16,
457-499.
|
 |
|
|
|
|
 |
Y.R.Thorstenson,
Y.Zhang,
P.S.Olson,
and
D.Mascarenhas
(1997).
Leaderless polypeptides efficiently extracted from whole cells by osmotic shock.
|
| |
J Bacteriol, 179,
5333-5339.
|
 |
|
|
|
|
 |
B.S.Chang,
R.M.Beauvais,
T.Arakawa,
L.O.Narhi,
A.Dong,
D.I.Aparisio,
and
J.F.Carpenter
(1996).
Formation of an active dimer during storage of interleukin-1 receptor antagonist in aqueous solution.
|
| |
Biophys J, 71,
3399-3406.
|
 |
|
|
|
|
 |
D.C.Ambrosetti,
E.Palla,
A.Mirtella,
C.Galeotti,
E.Solito,
P.Navarra,
L.Parente,
and
M.Melli
(1996).
Synthetic alleles at position 121 define a functional domain of human interleukin-1 beta.
|
| |
Eur J Biochem, 238,
308-316.
|
 |
|
|
|
|
 |
Y.Kato,
T.Muto,
T.Tomura,
H.Tsumura,
H.Watarai,
T.Mikayama,
K.Ishizaka,
and
R.Kuroki
(1996).
The crystal structure of human glycosylation-inhibiting factor is a trimeric barrel with three 6-stranded beta-sheets.
|
| |
Proc Natl Acad Sci U S A, 93,
3007-3010.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.A.Schreuder,
J.M.Rondeau,
C.Tardif,
A.Soffientini,
E.Sarubbi,
A.Akeson,
T.L.Bowlin,
S.Yanofsky,
and
R.W.Barrett
(1995).
Refined crystal structure of the interleukin-1 receptor antagonist. Presence of a disulfide link and a cis-proline.
|
| |
Eur J Biochem, 227,
838-847.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Svenson,
S.Nedergaard,
P.M.Heegaard,
T.D.Whisenand,
W.P.Arend,
and
K.Bendtzen
(1995).
Differential binding of human interleukin-1 (IL-1) receptor antagonist to natural and recombinant soluble and cellular IL-1 type I receptors.
|
| |
Eur J Immunol, 25,
2842-2850.
|
 |
|
|
|
|
 |
C.A.Dinarello
(1994).
Blocking interleukin-1 receptors.
|
| |
Int J Clin Lab Res, 24,
61-79.
|
 |
|
|
|
|
 |
J.M.Parker,
and
R.S.Hodges
(1994).
HomologyPlot: searching for homology to a family of proteins using a database of unique conserved patterns.
|
| |
J Comput Aided Mol Des, 8,
193-210.
|
 |
|
|
|
|
 |
A.E.Eriksson,
L.S.Cousens,
and
B.W.Matthews
(1993).
Refinement of the structure of human basic fibroblast growth factor at 1.6 A resolution and analysis of presumed heparin binding sites by selenate substitution.
|
| |
Protein Sci, 2,
1274-1284.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
F.Guinet,
J.D.Guitton,
N.Gault,
F.Folliard,
N.Touchet,
J.M.Cherel,
A.Crespo,
A.Destourbe,
P.Bertrand,
and
P.Denefle
(1993).
Interleukin-1 beta-specific partial agonists defined by site-directed mutagenesis studies.
|
| |
Eur J Biochem, 211,
583-590.
|
 |
|
|
|
|
 |
J.E.Wampler,
E.A.Bradley,
D.E.Stewart,
and
M.W.Adams
(1993).
Modeling the structure of Pyrococcus furiosus rubredoxin by homology to other X-ray structures.
|
| |
Protein Sci, 2,
640-649.
|
 |
|
|
|
|
 |
B.Veerapandian,
G.L.Gilliland,
R.Raag,
A.L.Svensson,
Y.Masui,
Y.Hirai,
and
T.L.Poulos
(1992).
Functional implications of interleukin-1 beta based on the three-dimensional structure.
|
| |
Proteins, 12,
10-23.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.Veerapandian
(1992).
Structure and function of interleukin-1, based on crystallographic and modeling studies.
|
| |
Biophys J, 62,
112-115.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.A.Stura,
P.Chen,
C.M.Wilmot,
J.H.Arevalo,
and
I.A.Wilson
(1992).
Crystallization studies of glycosylated and unglycosylated human recombinant interleukin-2.
|
| |
Proteins, 12,
24-30.
|
 |
|
|
|
|
 |
M.Billeter
(1992).
Comparison of protein structures determined by NMR in solution and by X-ray diffraction in single crystals.
|
| |
Q Rev Biophys, 25,
325-377.
|
 |
|
|
|
|
 |
M.D.Walkinshaw
(1992).
Protein targets for structure-based drug design.
|
| |
Med Res Rev, 12,
317-372.
|
 |
|
|
|
|
 |
T.Senda,
T.Shimazu,
S.Matsuda,
G.Kawano,
H.Shimizu,
K.T.Nakamura,
and
Y.Mitsui
(1992).
Three-dimensional crystal structure of recombinant murine interferon-beta.
|
| |
EMBO J, 11,
3193-3201.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.E.Eriksson,
L.S.Cousens,
L.H.Weaver,
and
B.W.Matthews
(1991).
Three-dimensional structure of human basic fibroblast growth factor.
|
| |
Proc Natl Acad Sci U S A, 88,
3441-3445.
|
 |
|
|
|
|
 |
E.Labriola-Tompkins,
C.Chandran,
K.L.Kaffka,
D.Biondi,
B.J.Graves,
M.Hatada,
V.S.Madison,
J.Karas,
P.L.Kilian,
and
G.Ju
(1991).
Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor.
|
| |
Proc Natl Acad Sci U S A, 88,
11182-11186.
|
 |
|
|
|
|
 |
G.Ju,
E.Labriola-Tompkins,
C.A.Campen,
W.R.Benjamin,
J.Karas,
J.Plocinski,
D.Biondi,
K.L.Kaffka,
P.L.Kilian,
and
S.P.Eisenberg
(1991).
Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis.
|
| |
Proc Natl Acad Sci U S A, 88,
2658-2662.
|
 |
|
|
|
|
 |
J.D.Zhang,
L.S.Cousens,
P.J.Barr,
and
S.R.Sprang
(1991).
Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta.
|
| |
Proc Natl Acad Sci U S A, 88,
3446-3450.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|